Matthew Espenshade, DO
Orthopaedic Surgery · Harrisburg, PANPI 1558561514
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $15,500 of the $15,661 with a category attached, or 99.0%. CTL Medical Corporation accounts for 99.0% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2020 at $9,013 and has fallen 99.8% since, to $16 in 2025.
Across 13 payments — averaging $1204.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- CTL Medical Corporation$16K
- Nextstep Arthropedix, LLC$81
- Medical Device Business Services, Inc.$19
- Johnson & Johnson$18
- Novus Surgical Consultants$16
- Bioventus LLC$13
- plus $13 from 1 others
What the payments were for
- Consulting fees$15,50099%
- Food & beverage$1611%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| CTL Medical Corporation | 7 | $15,500 |
| Nextstep Arthropedix, LLC | 1 | $81 |
| Medical Device Business Services, Inc. | 1 | $19 |
| Johnson & Johnson | 1 | $18 |
| Novus Surgical Consultants | 1 | $16 |
| Bioventus LLC | 1 | $13 |
| Amgen | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Spinal$5,000
How this compares
$15,661 in reported general payments places this provider in the 75th percentile of 1,048 orthopaedic surgery providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 112 | $629 |
| Diclofenac Sodium | 37 | $597 |
| Meloxicam | 253 | $564 |
| Methylprednisolone | 47 | $317 |
| Cephalexin | 209 | $267 |
| Gabapentin | 25 | $244 |
| Celecoxib | 27 | $237 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 25 | $149 |
| Tramadol Hcl | 59 | $132 |
| Naproxen | 14 | $63 |
| Clindamycin Hcl | 27 | $24 |
| Cyclobenzaprine Hcl | 13 | $13 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Harrisburg
- Walter PeppelmanHarrisburg$211K
- John GrandrimoHarrisburg$176K
- William HozackBensalem$10.6M
- Jess LonnerBryn Mawr$7.8M
- Gerald WilliamsBryn Mawr$6.8M
- Mark LazarusBensalem$6.4M
- John FenlinPhiladelphia$5.9M
- Peter SharkeyKing Of Prussia$5.7M
- Alexander VaccaroPhiladelphia$4.5M
- Selene ParekhBensalem$4.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.